Educational Reference · Research-Use-Only
GHK-Cu: Mechanism, Research, and Use Cases
A research-grade overview of GHK-Cu — what it is, how it works at the molecular level, what published studies have shown, and answers to the questions researchers ask most.
What is GHK-Cu?
GHK-Cu (glycyl-L-histidyl-L-lysine copper(II)) is a naturally occurring copper-binding tripeptide first isolated from human plasma albumin by Pickart and Thaler in 1973. It is present at concentrations of ~200 ng/mL in plasma of young adults, declining substantially with age. The peptide coordinates Cu(II) through the histidine imidazole nitrogen and N-terminal amine in a square planar complex.
This copper chelation is central to GHK-Cu's biological activity: the copper-peptide complex acts as a cellular copper chaperone, facilitating delivery to copper-dependent enzymes including lysyl oxidase (collagen cross-linking), superoxide dismutase (SOD1), and cytochrome c oxidase. At the cellular level, GHK-Cu activates multiple signaling pathways simultaneously. It upregulates collagen types I, III, and VI synthesis in dermal fibroblasts, stimulates production of glycosaminoglycans and proteoglycans, and promotes fibronectin and decorin expression — all components of extracellular matrix remodeling.
It modulates matrix metalloproteinase (MMP) activity bidirectionally: increasing MMP-2 and MMP-9 to clear damaged matrix while also upregulating TIMP-1 and TIMP-2 to control remodeling. Gene expression analysis (Connectivity Map) shows GHK can modulate expression of over 4,000 genes, including pathways involved in inflammation (NF-κB suppression), oxidative stress (Nrf2 activation), and DNA repair. In wound healing models, GHK-Cu stimulates angiogenesis via VEGF upregulation and accelerates keratinocyte migration.
Research highlights
What published peer-reviewed research and preclinical studies have established about GHK-Cu:
- 01Naturally occurring copper-binding tripeptide found in human plasma (~200 ng/mL), saliva, and urine; concentrations decline with age
- 02In vitro: stimulates collagen I, III, and VI synthesis in dermal fibroblasts; increases GAG and fibronectin production
- 03Connectivity Map analysis (Lamb 2007): GHK modulates >4,000 human genes including NF-κB, Nrf2, TGF-β, and VEGF pathways
- 04Preclinical wound healing models demonstrate accelerated re-epithelialization, angiogenesis (via VEGF), and anti-inflammatory activity
- 05Acts as copper chaperone: delivers Cu(II) to lysyl oxidase (collagen cross-linking), SOD1 (antioxidant), and cytochrome c oxidase (mitochondrial function)
- 06Topical formulations show improvement in skin elasticity, fine lines, and pigmentation in double-blind clinical cosmetic studies
- 07Anti-inflammatory activity: reduces TNF-α, IL-6, and IL-1β; suppresses NF-κB activation in macrophage and fibroblast models
Published clinical and preclinical research
Topical GHK-Cu for skin aging (double-blind cosmetic study)
Phase 2 (cosmetic) · 2005GHK-Cu cream vs placebo: significant improvement in skin elasticity (+40% vs baseline), reduction in fine line depth, improved skin density by ultrasound
GHK-Cu and collagen production (in vitro)
In vitro / mechanistic · 2015GHK-Cu (10 nM–10 μM) increased collagen synthesis 2–6x baseline in primary human dermal fibroblasts; dose-dependent response; no cytotoxicity
Gene expression network analysis
Bioinformatic / in vitro · 2012GHK regulates 4,096 human genes in the NCBI Connectivity Map; top pathways: DNA repair, ubiquitin, cancer suppressor activation, antioxidant defense, anti-inflammatory
Frequently asked questions about GHK-Cu
What is the difference between GHK and GHK-Cu?+
GHK refers to the free tripeptide (glycyl-histidyl-lysine). GHK-Cu is the copper-complexed form, where Cu(II) is coordinated in a square planar arrangement with the histidine imidazole nitrogen and N-terminal amine. Most published research uses the copper complex (GHK-Cu), which is biologically active. The free peptide (GHK) has high copper affinity and rapidly chelates endogenous copper after administration; however, commercial research preparations are typically sold as the copper complex.
How should GHK-Cu be reconstituted and stored?+
Dissolve lyophilized GHK-Cu in sterile or bacteriostatic water, or normal saline, at your target concentration. GHK-Cu is water-soluble and dissolves readily. Typical research concentrations: 0.5–2 mg/mL. The solution should appear a light blue-green color (characteristic of the copper complex). Store reconstituted solution at 2–8°C, protected from light, for up to 30 days. Avoid freeze-thaw cycles of reconstituted solution.
What does the blue-green color of GHK-Cu indicate?+
The characteristic blue-green color is caused by the Cu(II) d-d electronic transition in the square planar coordination complex. This is expected and indicates intact copper chelation. A colorless solution may suggest the copper has dissociated or the compound is the free peptide without copper. Color intensity is proportional to concentration.
Is GHK-Cu being studied for wound healing in human trials?+
Most wound healing data for GHK-Cu is preclinical (animal models, in vitro). A number of cosmetic clinical trials have examined topical GHK-Cu for skin aging with positive results. No large-scale Phase 2/3 randomized controlled trials have evaluated injectable GHK-Cu for wound healing in humans to date. The primary published human evidence base is in topical cosmetic applications.
What gene pathways does GHK-Cu modulate?+
Connectivity Map analysis identified GHK as one of the most broadly acting peptides in the human transcriptome — affecting over 4,000 genes. Key pathways include: NF-κB suppression (anti-inflammatory), Nrf2 activation (antioxidant), TGF-β signaling (collagen production), VEGF upregulation (angiogenesis), ubiquitin-proteasome pathway (protein degradation/clearance), and multiple DNA damage response and repair genes. This breadth of activity underlies research into diverse applications from skin aging to potential neuroprotection.
Can GHK-Cu be used topically and via subcutaneous injection in the same research protocol?+
Yes. Topical and subcutaneous routes have different bioavailability profiles. Topical GHK-Cu is absorbed transdermally with lower systemic exposure; SC injection provides direct systemic delivery. Some research protocols evaluate both routes in parallel to compare tissue-level vs systemic effects. Topical cosmetic safety is well-established; systemic (injectable) safety data in humans is more limited.
How does GHK-Cu's activity change with age?+
Plasma GHK levels decline from ~200 ng/mL in young adults to <80 ng/mL by age 60. This age-related decline parallels decreases in skin collagen content, wound healing capacity, and antioxidant defenses. Pickart and colleagues have proposed that GHK supplementation may help restore some of these age-related deficits, though large prospective human trials testing this hypothesis have not been completed.
Is GHK-Cu approved or regulated as a drug?+
GHK-Cu is not approved as a pharmaceutical drug by the FDA. It is used widely in cosmetic products and is generally recognized as safe for topical use at cosmetic concentrations. For injectable research use, GHK-Cu falls under research chemical regulations and is not subject to pharmaceutical approval requirements. It does not appear on WADA prohibited lists.
References
- [1]Pickart L, Vasquez-Soltero JM, Margolina A.. GHK peptide as a natural modulator of multiple cellular pathways in skin regeneration. BioMed Research International. 2015. PMID: 25861634 DOI: 10.1155/2015/648108
- [2]Pickart L, Vasquez-Soltero JM, Margolina A.. GHK-Cu may prevent oxidative stress in skin by regulating copper and modifying expression of numerous antioxidant genes. Cosmetics. 2015. DOI: 10.3390/cosmetics2030236
- [3]Pickart L, Margolina A.. Regenerative and protective actions of the GHK-Cu peptide in the light of the new gene data. International Journal of Molecular Sciences. 2018. PMID: 29949889 DOI: 10.3390/ijms19071987
- [4]Lamb J.. The Connectivity Map: a new tool for biomedical research. Nature Reviews Cancer. 2007. PMID: 17186018 DOI: 10.1038/nrc2044
- [5]Maquart FX, Pickart L, Laurent M, et al.. Stimulation of collagen synthesis in fibroblast cultures by the tripeptide-copper complex glycyl-L-histidyl-L-lysine-Cu2+. FEBS Letters. 1988. PMID: 3366166 DOI: 10.1016/0014-5793(88)81446-4
- [6]Lesage C, Augustin M.. Evaluation of a copper tripeptide complex in the treatment of photoaged facial skin. Clinical and Experimental Dermatology. 2006. PMID: 16618251 DOI: 10.1111/j.1365-2230.2006.02132.x
- [7]Buffoni F, Pino R, Dal Pozzo A.. Effect of tripeptide-copper complexes on the process of skin wound healing and on cultured fibroblasts. Archives Internationales de Pharmacodynamie et de Thérapie. 1995. PMID: 8527854
Regulatory status
GHK-Cu is widely used in topical cosmetic formulations and is not classified as a pharmaceutical drug. Injectable GHK-Cu has no approved therapeutic indication. It does not appear on WADA prohibited substance lists. For research purposes only in injectable form.
Researching GHK-Cu?
We carry GHK-Cu for laboratory research.
99%+ HPLC purity, third-party tested, same-day US shipping. Every batch ships with a published certificate of analysis.